A phase I/II, two-arm, multicenter, dose escalation study of oral AEE788 administered on a continuous once daily dosing schedule in adult patients with recurrent or relapsing glioblastoma multiforme.
Phase of Trial: Phase I/II
Latest Information Update: 11 Nov 2015
At a glance
- Drugs AEE 788 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 05 Jul 2007 Status changed from in progress to completed.
- 02 Sep 2005 New trial record.